From Imaging to Impact: PERSONALISE-DKD at the Kármán Conference
Kidney disease affects hundreds of millions of people worldwide, yet so much of what happens inside this vital organ remains difficult to see without invasive
Uncovering early mechanisms and predictors of how patients with diabetic kidney disease respond to SGLT2 inhibitors, using advanced MRI and molecular biomarkers
Aiming to refine and validate these biomarkers to enable personalised treatment, better monitoring of disease progression, and more effective patient care.
Kidney disease affects hundreds of millions of people worldwide, yet so much of what happens inside this vital organ remains difficult to see without invasive
The annual Personalise-DKD project meeting was held in University of Latvia House of Science, Riga, Latvia, on 1 July, bringing together project partners and researchers
🌐World Kidney Day 2026: Kidney Health For All – Caring for People, Protecting the Planet Today, as we join hands globally to mark World Kidney
